In vivo studies have found that salidroside may inhibit NF-κB signaling and reduce pIκBα and p-NF-κBp65 protein expression in the lungs of COPD mice, thus effectively protecting against lung injury in COPD mice (Carozzi et al., 2017). The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.